Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era

Tatsuo Kanda; Reina Sasaki-Tanaka; Tomotaka Ishii; Hayato Abe; Masahiro Ogawa; Hirayuki Enomoto

doi:10.3390/jcm11144249

Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era

J Clin Med. 2022 Jul 21;11(14):4249. doi: 10.3390/jcm11144249.

Authors

Tatsuo Kanda¹, Reina Sasaki-Tanaka¹, Tomotaka Ishii¹, Hayato Abe², Masahiro Ogawa¹, Hirayuki Enomoto³

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
² Department of Digestive Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
³ Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya 663-8501, Japan.

Abstract

Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF), respectively, occur in patients with normal liver and patients with chronic liver diseases, including cirrhosis [...].

Publication types

Editorial

Grants and funding

JP22fk0210075h0003/Japan Agency for Medical Research and Development